Revenue from Contract with Customer, Excluding Assessed Tax in USD of Dare Bioscience, Inc. from Q1 2020 to Q3 2025
-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.
-
Summary
-
Dare Bioscience, Inc. quarterly/annual Revenue from Contract with Customer, Excluding Assessed Tax history and change rate from Q1 2020 to Q3 2025.
- Dare Bioscience, Inc. Revenue from Contract with Customer, Excluding Assessed Tax for the quarter ending 30 Sep 2025 was $2.26K, a 94.6% decline year-over-year.
- Dare Bioscience, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2024 was $9.78K, a 99.7% decline from 2023.
- Dare Bioscience, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2023 was $2.81M, a 27979% increase from 2022.
- Dare Bioscience, Inc. annual Revenue from Contract with Customer, Excluding Assessed Tax for 2022 was $10K.
Revenue from Contract with Customer, Excluding Assessed Tax, Trailing 12 Months (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, Quarterly (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Quarterly Change (%)
Revenue from Contract with Customer, Excluding Assessed Tax, Annual (USD)
Revenue from Contract with Customer, Excluding Assessed Tax, YoY Annual Change (%)